
Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
26 December 2023
Editorial Board Members from the Journal of Clinical Medicine Featured in the 2023 Highly Cited Researchers List Published by Clarivate

Recently, ClarivateTM revealed its 2023 list of Highly Cited ResearchersTM—individuals at universities, research institutes, and commercial organizations.
The scientists who were selected for this year’s list of Highly Cited Researchers published highly cited papers in the 11-year period from January 2012 to December 2022, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. This year, 7125 Highly Cited Researcher 2023 designations were issued to 6849 individuals, representing just 1 in 1000 researchers worldwide. This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. The list is truly global, spanning 67 countries or regions and spread across a diverse range of research sciences and social sciences.
According to our statistics, 8 members of the Editorial Board of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) were selected for the list of Highly Cited Researchers by ClarivateTM in 2023. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields. The JCM Editorial Office sincerely congratulates all elected editorial members and hopes that they continue to have an academically productive relationship with the journal.
Researcher |
|
Category |
Affiliation |
|
Lancellotti, Patrizio |
Clinical Medicine |
University of Liege, Belgium |
|
Timsit, Jean-Francois |
Cross-Field |
Université Paris Cité, France |
|
Young, Allan H. |
Cross-Field |
King's College London, United Kingdom |
|
Graus, Francesc |
Neuroscience and Behavior |
University of Barcelona, Spain |
|
Vita, Antonio |
Psychiatry and Psychology |
University of Brescia, Italy |
![]() |
Landi, Francesco |
Cross-Field |
Catholic University of the Sacred Heart, Italy |
Rocca, Maria A. |
Neuroscience and Behavior |
Vita-Salute San Raffaele University, Italy |
|
Carvalho, Andre F. |
Psychiatry and Psychology |
Deakin University, Australia |
To access more information about the JCM Editorial Board, please visit the following link: https://www.mdpi.com/journal/jcm/editors.
26 December 2023
2023 Journal of Clinical Medicine Editorial Board Meeting of the Section “Cardiology” Held on 21 November 2023

It is our great pleasure to share the news that the 2023 Journal of Clinical Medicine (JCM, ISSN: 2077-0383) Editorial Board Meeting of the Section “Cardiology” was held on 21 November 2023, conducted by the Section Editor-in-Chiefs, Prof. Dr. Maciej Banach and Prof. Dr. Gregory Y. H. Lip.
The meeting started with a presentation about the development of the journal and the Section “Cardiology”, with the following information presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), open access benefits, journal awards, conference sponsorship, and promotion on social media;
- Section Editorial Board Member distribution, decision-making statistics, and Section statistics.
The meeting mainly discussed the quality control of manuscripts, feature paper invitations, reviewer awards, the direction of article types, Special Issue collaboration, conference suggestions, and social media promotion. Based on the discussion, the journal plans to enrich reviewer award applications, be more present at conferences in the field, keep an eye on hot topics and research fronts, and have social media ambassadors to improve promotion.
We would like to thank every Editorial Board Member and the academics for their great support. We look forward to receiving more support and suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Prof. Dr. Maciej Banach, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz, Poland; Johns Hopkins University School of Medicine, Baltimore, MD, USA;
- Prof. Dr. Gregory Y. H. Lip, University of Liverpool, Liverpool, UK; Aalborg University, Aalborg, Denmark;
- Prof. Dr. Massimiliano Ruscica, Università degli Studi di Milano, Milan, Italy;
- Prof. Dr. Filippos Triposkiadis, University of Thessaly, Larissa University General Hospital, Larissa, PO, Greece;
- Prof. Dr. Manuel Martínez-Sellés, Hospital General Universitario Gregorio Marañón, Calle Doctor Esquerdo, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain;
- Prof. Dr. Sheldon Goldberg, University of Pennsylvania Health System, Philadelphia, PA, USA;
- Prof. Dr. Gani Bajraktari, Umeå University and Heart Centre, Umeå, Sweden; University Clinical Centre of Kosova, Prishtina, Kosovo;
- Prof. Dr. Laurent Fauchier, Centre Hospitalier Universitaire Trousseau, Faculté de Médecine, Université de Tours, Avenue de la-République, Tours, France;
- Prof. Dr. Manuel Martínez-Sellés, Hospital General Universitario Gregorio Marañón, Calle Doctor Esquerdo, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain;
- Dr. Chirag Bavishi, University of Missouri, Columbia, MO, USA;
- Dr. Karl-Philipp Rommel, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
The latest official CiteScore (2022 Scopus data) of the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the area of “General Medicine”. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the category “Medicine, General & Internal”.
To access more journal statistics, please click here.
To access more Section information, please visit the following link: https://www.mdpi.com/journal/jcm/sections/JCM_Cardiology.
20 December 2023
Interview with Dr. Víctor Marcos Garcés—Winner of the JCM 2022 Ph.D. Thesis Award

We had the pleasure of speaking with Dr. Víctor Marcos Garcés, winner of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) 2022 Ph.D. Thesis Award.
![]() |
Name: Dr. Víctor Marcos Garcés Affiliation: 1.Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain; |
Dr. Víctor Marcos Garcés is a cardiologist and gained his Doctor in Medicine degree from the University of Valencia, Spain. He has shown special interest in clinical and preventive cardiology, cardiac rehabilitation, and cardiac imaging techniques, pursuing postgraduate university training in these areas. In January 2022, he initiated the Post-Myocardial Infarction Cardiac Rehabilitation Program at the University Clinical Hospital of Valencia, Spain. Dr. Víctor Marcos Garcés also has extensive research experience, emphasizing various aspects of cardiac imaging techniques (especially cardiac magnetic resonance), basic and translational research, and, in recent years, preventive cardiology and cardiac rehabilitation. He has published 47 articles in scientific journals (with half of them being published in first decile or quartile journals), participated in 8 competitive research projects, and presented more than 150 abstracts at scientific congresses, with more than 50 of them being international congresses. He has received several awards throughout his career, such as the Extraordinary Ph.D. Award from the University of Valencia, the Final Residency Award, and the García Blanco Medal-Award in its 42nd edition.
We hope you enjoy the interview.
We wish Dr. Víctor Marcos Garcés every success in his current work, and we look forward to his future contributions to the journal.
For more information about the awards presented by JCM, please visit the following link: https://www.mdpi.com/journal/jcm/awards.
We wish Dr. Víctor Marcos Garcés every success in his current work, and we look forward to his future contributions to the journal.
For more information about the awards presented by JCM, please visit the following link: https://www.mdpi.com/journal/jcm/awards.
1 December 2023
Journal of Clinical Medicine | Collaboration Established with the Italian Society of Thoracic Endoscopy (SIET)
|
In September 2023, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has established a cooperation with the Italian Society of Thoracic Endoscopy (SIET). As part of this collaboration, all members of SIET will enjoy a discount on the Article Processing Charge (APC) when submitting articles to JCM. The collaboration goes beyond the discount benefit offered to members and includes other services as well as cross-promotions. Italian Society of Thoracic Endoscopy was founded as an Italian organization in 1980. However, it now has members from all over the European continent. SIET is a dynamic and young scientific society that plays a leading role in endoscopy and minimally invasive thoracic surgery. |
SIET is a professional organization whose functions are highly relevant to the scope of JCM. We look forward to collaborating with SIET and publishing state-of-the-art research from its members in this field.
For more information about societies cooperated with JCM, please visit: https://www.mdpi.com/journal/jcm/societies.
30 November 2023
MDPI Insights: The CEO's Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Spain Summit
Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.
On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.
With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.
The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.
The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.
Connecting with Editorial Board Members
Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."
Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.
From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.
As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.
Open Access in Spain
In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.
For further details of Spain's OA policy and the history of government mandates, click here.
Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus.
A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!
MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.
I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.
Impactful Research
769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023
Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.
Click here to view the full list of 769 Editorial Board Members.
Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.
Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!
Inside MDPI
Corporate Marketing and Communications Strategy Session
Members of MDPI’s Corporate Marketing & Communications team.
For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.
This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.
We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.
The strategy session also serves as a team-building activity, during which the team voted on bowling!
Strategy Session
In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.
To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.
I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.
Coming Together for Science
ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home
Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.
When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.
In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.
While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.
The press release below provides further details.
Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023
ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.
This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.
Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.
Closing Thoughts
November is Men’s Health Awareness Month
Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.
November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.
I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.
Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.
Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.
Healthy men help build healthy families and a healthy society
Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.
From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.
Mindfulness
Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:
Chief Executive Officer
MDPI AG
28 November 2023
Journal of Clinical Medicine | Highly Cited Papers in the Section “Gastroenterology & Hepatopancreatobiliary Medicine”

Journal of Clinical Medicine (JCM, ISSN: 2077-0383) publishes high-quality original research, reviews, and systematic reviews that contribute to advancing clinical health and medicine. As JCM is of open access format, you have free and unlimited access to the full text of all the articles published in it.
We welcome you to read the highly cited papers published in 2022 in the Section “Gastroenterology & Hepatopancreatobiliary Medicine”.
1. “Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022?”
by Marilena Durazzo, Arianna Ferro, Isabella Brascugli, Simone Mattivi, Sharmila Fagoonee and Rinaldo Pellicano
J. Clin. Med. 2022, 11(1), 258; https://doi.org/10.3390/jcm11010258
Available online: https://www.mdpi.com/2077-0383/11/1/258
2. “The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus”
by Marcin Kosmalski, Sylwia Ziółkowska, Piotr Czarny, Janusz Szemraj and Tadeusz Pietras
J. Clin. Med. 2022, 11(5), 1375; https://doi.org/10.3390/jcm11051375
Available online: https://www.mdpi.com/2077-0383/11/5/1375
3. “The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?”
by Matteo Renzulli, Anna Pecorelli, Nicolò Brandi, Stefano Brocchi, Francesco Tovoli, Alessandro Granito, Gianpaolo Carrafiello, Anna Maria Ierardi and Rita Golfieri
J. Clin. Med. 2022, 11(15), 4399; https://doi.org/10.3390/jcm11154399
Available online: https://www.mdpi.com/2077-0383/11/15/4399
4. “Current Status and Future Perspectives of Artificial Intelligence in Colonoscopy”
by Yu Kamitani, Kouichi Nonaka and Hajime Isomoto
J. Clin. Med. 2022, 11(10), 2923; https://doi.org/10.3390/jcm11102923
Available online: https://www.mdpi.com/2077-0383/11/10/2923
5. “Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies”
by Cristina Rubín de Célix, María Chaparro and Javier P. Gisbert
J. Clin. Med. 2022, 11(14), 4202; https://doi.org/10.3390/jcm11144202
Available online: https://www.mdpi.com/2077-0383/11/14/4202
6. “Ulva pertusa, a Marine Green Alga, Attenuates DNBS-Induced Colitis Damage via NF-κB/Nrf2/SIRT1 Signaling Pathways”
by Alessio Ardizzone, Alessia Filippone, Deborah Mannino, Sarah Adriana Scuderi, Giovanna Casili, Marika Lanza, Laura Cucinotta, Michela Campolo and Emanuela Esposito
J. Clin. Med. 2022, 11(15), 4301; https://doi.org/10.3390/jcm11154301
Available online: https://www.mdpi.com/2077-0383/11/15/4301
7. “COVID-19 Pneumonia and Gut Inflammation: The Role of a Mix of Three Probiotic Strains in Reducing Inflammatory Markers and Need for Oxygen Support”
by Angela Saviano, Annalisa Potenza, Valentina Siciliano, Carmine Petruzziello, Claudia Tarli, Alessio Migneco, Flavia Nasella, Francesco Franceschi and Veronica Ojetti
J. Clin. Med. 2022, 11(13), 3758; https://doi.org/10.3390/jcm11133758
Available online: https://www.mdpi.com/2077-0383/11/13/3758
8. “Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways”
by Laure-Alix Clerbaux, Julija Filipovska, Amalia Muñoz, Mauro Petrillo, Sandra Coecke, Maria-Joao Amorim and Lucia Grenga
J. Clin. Med. 2022, 11(18), 5400; https://doi.org/10.3390/jcm11185400
Available online: https://www.mdpi.com/2077-0383/11/18/5400
9. “Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)”
by Olga P. Nyssen, Dino Vaira, Ilaria Maria Saracino, Giulia Fiorini, María Caldas, Luis Bujanda, Rinaldo Pellicano, Alma Keco-Huerga, Manuel Pabón-Carrasco, Elida Oblitas Susanibar et al.
J. Clin. Med. 2022, 11(6), 1658; https://doi.org/10.3390/jcm11061658
Available online: https://www.mdpi.com/2077-0383/11/6/1658
10. “Suppurative Thrombosis of the Portal Vein (Pylephlebits): A Systematic Review of Literature”
by Dorde Jevtic, Tatjana Gavrancic, Ivana Pantic, Terri Nordin, Charles W. Nordstrom, Marina Antic, Nikola Pantic, Marija Kaljevic, Bojan Joksimovic, Milan Jovanovic et al.
J. Clin. Med. 2022, 11(17), 4992; https://doi.org/10.3390/jcm11174992
Available online: https://www.mdpi.com/2077-0383/11/17/4992
Access more Section information here.
21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023

We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.
Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!
Abate, Antonio |
Jaiswal, Amit K. |
Shen, Zexiang |
15 November 2023
2023 Journal of Clinical Medicine Editorial Board Meeting of Section “Endocrinology & Metabolism” Held on 5 and 18 September 2023

It is our great pleasure to share the news that the 2023 Journal of Clinical Medicine (JCM) Editorial Board Meeting of Section “Endocrinology & Metabolism” was held on 5 and 18 September 2023, conducted by the Section Editor-in-Chief, Prof. Dr. Didac Mauricio.
The meeting started with a presentation about the journal and Section “Endocrinology & Metabolism” development with the following information presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), open access benefits, journal awards, conference sponsorship, promotion on social media;
- Section aims and scope, Editorial Board Member distribution and decision-making statistics, Section statistics, highly cited papers.
The meeting mainly discussed keyword expansion and revision of the Section website, as well as other topics such as Academic Editor decisions, Section title, Section competitiveness, manuscript processing flow, Special Issue series, and feature paper invitations. Based on the discussion, some keywords may be added to the Section website, such as therapy of obesity, diabetes, metabolic bone diseases/disorders, prevention of endocrine diseases, pediatric endocrinology, etc. We will keep an eye out for more proposals and maintain regular communication with the Editorial Board Members to further the Section's growth.
This Section Editorial Board online meeting aims to increase support for the Section's and the journal's next development. We would like to thank every Editorial Board Member and the academics for their support again. We look forward to receiving more support and suggestions and making common progress.
Attendee list (in no particular order):
Part I (5 September 2023):
- Prof. Dr. Didac Mauricio, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain; University of Vic & Central University of Catalonia, Barcelona, Spain; Instituto de Salud Carlos III, Barcelona, Spain;
- Prof. Dr. Luigi Uccioli, University of Rome Tor Vergata, Rome, Italy;
- Prof. Dr. Brian Tomlinson, Macau University of Science and Technology, Macau; The Chinese University of Hong Kong, Hong Kong;
- Dr. Sheyu Li, West China Hospital of Sichuan University, Chengdu, China.
Part II (18 September 2023):
- Prof. Dr. Didac Mauricio, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain; University of Vic & Central University of Catalonia, Barcelona, Spain; Instituto de Salud Carlos III, Barcelona, Spain;
- Dr. John Griffith Jones, University of Coimbra, Coimbra, Portugal;
- Prof. Dr. Gyanendra Tripathi, University of Derby, Derby, UK;
- Prof. Dr. Alejandro Gugliucci, Touro University California, Vallejo, CA, USA;
- Prof. Dr. Neveen Agnes Therese Hamdy, Leiden University Medical Center, University of Leiden, Leiden, the Netherlands;
- Prof. Dr. Cees Noordam, Centre for Paediatric Endocrinology Zurich (PEZZ), Zurich, Switzerland; Radboud University Medical Centre, Nijmegen, the Netherlands;
- Dr. Ishwarlal Jialal, UCDAVIS School of Medicine, Sacramento, CA, USA.
The latest official CiteScore (2022 Scopus data) of the Journal of Clinical Medicine (ISSN: 2077-0383) is 5.4, ranking 137/830 (Q1) in the area of “General Medicine”. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the category “Medicine, General & Internal”.
To access more journal statistics please click here.
To access more Section information, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Endocrinology_Metabolism.
9 November 2023
Interview with Dr. Francesco Restelli—Winner of the JCM 2023 Travel Award

Name: Dr. Francesco Restelli
Affiliation: 1. Neurovascular Unit and Revascularization Unit, the Foundation IRCCS Neurological Institute “C. Besta,” Milan, Italy;
2. Italian Society of Neurosurgery and the European Association of Neurosurgical Societies.
We wish to congratulate Dr. Francesco Restelli on winning the JCM 2023 Travel Award. Dr. Francesco Restelli, MD., is an attending neurosurgeon of the Neurovascular Unit and the Revascularization Unit at the Foundation IRCCS Neurological Institute “C. Besta” in Milano. Dr. Restelli’s expertise includes cerebrovascular disorders (aneurysm, AVM, cavernomas, and moyamoya disease and stroke), brain, skull base, and intramedullary tumors.
He is a member of the Italian Society of Neurosurgery and the European Association of Neurosurgical Societies. Dr. Restelli received his medical degree and neurosurgery residency at the University of Milano. He completed a neurosurgical fellowship at the Arkansas Neuroscience Institute in Little Rock, Arkansas.
Dr. Restelli's research activities include the development of new visualization techniques during surgical approaches for oncological and vascular disease, particularly involving intraoperative fluorescence, developing new surgical techniques for cerebral revascularization, and anatomical studies of neurosurgical approaches. In the last five years, he has won five international awards related to neurosurgical research, and he is the author and co-author of over 40 peer-reviewed articles and four book chapters.
The following is an interview with Dr. Francesco Restelli:
1. How does it feel to receive this recognition for your work?
It was an honor; I feel very good because, for a researcher, having your work recognized that it is good enough to win a prize, is wonderful.
2. Where do you obtain journal award participation information?
My mentor, Prof. Dr. Francesco Acerbi, here at our neurological institute, suggested I apply for this recognition. Our group recently published many papers in your journal, and he probably received some emails about it. So, he was the one who suggested I apply.
3. Have you promoted it at a conference? In addition to promoting at the conference, how do you prefer to share the journal with your community?
In 2023, emails and notes on social media are the mainstream way for scientific diffusion. So I think that these ways would be my preferred ones.
4. How did winning this award impact your career, and what do you hope to do?
This kind of award is fundamental to my professional career and future. We are now working on the future steps of our project and trying to push it to the next clinical level.
5. Could you please briefly introduce your research direction for those who may not be familiar with it?
Confocal microscopy is a new technique that obtains images intraoperatively at the microscopic level during surgeries without needing standings or fixations using classical histological techniques. So basically, with this machine, the operator can obtain intraoperatively virtual histological images during the surgery an infinite number of times. So you can check inside and outside the tumor area, at the tumor bed, etc. Of course, in neurological surgery, as in my case, this aspect could have a significant role in the near future, as the microscopic vision of tumor tissue, particularly at the margins of resection of the intra-axial or glial tumor, could increase the extent of resection, leading to an increase in postoperative survival, hopefully.
6. What inspired you to follow this line of research?
Our group at Besta Institute, headed by Dr. Ferroli and Dr. Acerbi, has been very active in intraoperative imaging surgery in the last 20–25 years. So, following this path was a natural, consecutive step.
7. What do you think sets your research apart from others?
I think that our study was the first available in the literature where a machine's ability, named CONVIVO, was studied prospectively and blindly. For instance, similar works have been performed in recent years by different groups, but almost every study was characterized by not completely controlled designs or a low number of patients. For instance, only gliomas were often included in the surgical cohorts. Furthermore, in similar works, the analysis at the margins of the tumors has always been uncontrolled, with consecutively poor results in accuracy, sensitivity, sensitivity, and specificity.
8. How do you see your research findings impacting the field of clinical medicine and other related research areas?
Confocal microscopy has been widely used in medical clinical fields in recent years, such as gastroenterology, dermatology, gynecology, and neurosurgery. It is a wonderful technology because it permits physicians, clinicians, and surgeons to have live histological images during a procedure, an exam, an endoscopy, or surgery. I think this aspect may have very relevant insights in all the fields of clinical medicine, but especially for neurosurgery, where we all need to check the difference between a normal brain and a pathologic brain, and this difference during surgery is not always easy to find. Hence, having a machine that permits the physician to check whether tissue is pathologic is very interesting.
9. What are the next steps for this research?
We just concluded a 75-patient prospective study and presented the results at several international meetings. I think the two consecutive steps would be creating a common and worldwide shared database to increase the amount of collected data regarding rarer pathologies, not just metastasis and gliomas because for pathologies that are encountered less frequently, the data are still suboptimal. The other aspect is that we still need to study the real effectiveness of this kind of technology regarding the extent of resection, especially in intra-axial tumors. This aspect is just hypothesized for now, but we need to keep going and create a clinical protocol to check the difference in the extent of resection and overall survival in patients, considering if they are operated on with the aid of CONVIVO.
10. Do you have any advice for aspiring researchers in the field?
I have some advice. First, this is a very interesting field, but it requires physicians and surgeons to increase their skill in visualizing histological images. In Italy, for example, a neurosurgical resident's ability to analyze histological images is not commonly requested (and tested) in the residency program. So, regarding this aspect, I suggest that other researchers keep their minds open. I think the more a professional figure can analyze different aspects of his proper research, from the histological image analysis to the statistical analysis, the more comprehensive and interesting ideas could become because the researcher has the instruments to talk with everyone and share ideas.
A second piece of advice that I would give everyone is not to hesitate to contact colleagues worldwide to take a tour and look at their work. In scientific papers, it very often is impossible to present all those clinical, blurred, and accessory aspects that represent ingredients necessary for good clinical results, regardless of the main theme of the research. Once again, keep your mind open and travel.
11. What is your opinion of the open access model of publishing?
Science is based on information sharing, which is the only way to improve research. Therefore, every option that permits authors to increase the diffusion of their thinking and work should always be welcomed.
You can find more information about JCM Awards at the following link: https://www.mdpi.com/journal/jcm/awards. To request further information, please contact the JCM Editorial Office (jcm@mdpi.com).
Journal of Clinical Medicine Editorial Office
1 November 2023
MDPI Insights: The CEO's Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access Week 2023 – the Global Drive to Open Continues
As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.
International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.
Core principles of OA publishing
Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.
One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.
OA holds the potential to democratize knowledge, advance science, and drive positive societal change.
Policy driving change
Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the US, EU and China.
OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.
Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.
For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.
MDPI is proud to lead the transition to open access.
Read more:
Impactful Research
Spotlight on Smart Cities
Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.
As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.
Highly cited papers in Smart Cities
Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.
1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities”
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.
2. “A Review on Electric Vehicles: Technologies and Challenges”
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.
3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges”
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.
4. “Artificial Intelligence Techniques in Smart Grid: A Survey”
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.
5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures”
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.
Testimonial
“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators.” – Dr. Luís Rosa, University of Minho
Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility
Inside MDPI
MDPI Manchester office, UK Visit
Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.
In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.
Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.
I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.
The UK by numbers
The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.
As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.
According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.
We are currently hiring EEs in various locations worldwide.
English Editing at MDPI
Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.
While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.
Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.
Testimonials
“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam
“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño
Read more:
Coming Together for Science
STM and Frankfurt Book Fair
Attending STM
MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.
Meeting with Web of Science
On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.
“We discussed ways to improve our communication and collaboration.”
I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.
75th Frankfurt Book Fair
Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.
For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.
MDPI Books
Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?
The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.
If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.
Closing Thoughts
MDPI Strategy Meeting
As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.
Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.
“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”
As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!
Chief Executive Officer
MDPI AG